Oxycodone is a semisynthetic opioid analgesic derived from thebaine in Germany in 1917.[A178696] It is currently indicated as an immediate release product for moderate to severe pain and as an extended release product for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period.[Label] The first oxycodone containing product, Percodan, was approved by the FDA on April 12, 1950.[L6460]
Oxycodone is indicated for the treatment of moderate to severe pain.[Label] There is also an extended release formulation indicated for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period.[Label]
Categories
Alkaloids
Analgesics
Central Nervous System Agents
Central Nervous System Depressants
Cytochrome P-450 CYP2D6 Substrates
Cytochrome P-450 CYP3A Substrates
Cytochrome P-450 CYP3A4 Substrates
Cytochrome P-450 CYP3A5 Substrates
Cytochrome P-450 Substrates
Heterocyclic Compounds, Fused-Ring
Morphinans
Morphine Derivatives
Narcotics
Natural Opium Alkaloids
Nervous System
Opiate Agonists
Opiate Alkaloids
Opioid Agonist
Opioids
Peripheral Nervous System Agents
Phenanthrenes
Semi-synthetic Opioids
Sensory System Agents
Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
